Literature DB >> 10756095

The human homolog of insect-derived growth factor, CECR1, is a candidate gene for features of cat eye syndrome.

M A Riazi1, P Brinkman-Mills, T Nguyen, H Pan, S Phan, F Ying, B A Roe, J Tochigi, Y Shimizu, S Minoshima, N Shimizu, M Buchwald, H E McDermid.   

Abstract

Cat eye syndrome (CES) is a developmental disorder with multiple organ involvement, associated with the duplication of a 2-Mb region of 22q11.2. Using exon trapping and genomic sequence analysis, we have isolated and characterized a gene, CECR1, that maps to this critical region. The protein encoded by CECR1 is similar to previously identified novel growth factors: IDGF from Sarcophaga peregrina (flesh fly) and MDGF from Aplysia californica (sea hare). The CECR1 gene is alternatively spliced and expressed in numerous tissues, with most abundant expression in human adult heart, lung, lymphoblasts, and placenta as well as fetal lung, liver, and kidney. In situ hybridization of a human embryo shows specific expression in the outflow tract and atrium of the developing heart, the VII/VIII cranial nerve ganglion, and the notochord. The location of this gene in the CES critical region and its embryonic expression suggest that the overexpression of CECR1 may be responsible for at least some features of CES, particularly the heart defects. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10756095     DOI: 10.1006/geno.1999.6099

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  20 in total

1.  Adenosine deaminase-related growth factors stimulate cell proliferation in Drosophila by depleting extracellular adenosine.

Authors:  Michal Zurovec; Tomas Dolezal; Michal Gazi; Eva Pavlova; Peter J Bryant
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Genetic analysis of the ADGF multigene family by homologous recombination and gene conversion in Drosophila.

Authors:  Tomas Dolezal; Michal Gazi; Michal Zurovec; Peter J Bryant
Journal:  Genetics       Date:  2003-10       Impact factor: 4.562

3.  Candidate genetic modifiers of retinitis pigmentosa identified by exploiting natural variation in Drosophila.

Authors:  Clement Y Chow; Keegan J P Kelsey; Mariana F Wolfner; Andrew G Clark
Journal:  Hum Mol Genet       Date:  2015-12-11       Impact factor: 6.150

4.  Transgenic expression of CECR1 adenosine deaminase in mice results in abnormal development of heart and kidney.

Authors:  Ali M Riazi; Glen Van Arsdell; Manuel Buchwald
Journal:  Transgenic Res       Date:  2005-06       Impact factor: 2.788

5.  Structural basis for the growth factor activity of human adenosine deaminase ADA2.

Authors:  Anton V Zavialov; Xiaodi Yu; Dorothe Spillmann; Grégoire Lauvau; Andrey V Zavialov
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

6.  Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity.

Authors:  Andrey V Zavialov; Ake Engström
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

Review 7.  Genomic disorders on 22q11.

Authors:  Heather E McDermid; Bernice E Morrow
Journal:  Am J Hum Genet       Date:  2002-03-29       Impact factor: 11.025

8.  Partial tetrasomy of chromosome 22q11.1 resulting from a supernumerary isodicentric marker chromosome in a boy with cat-eye syndrome.

Authors:  Jung Min Ko; Jun Bum Kim; Ki Soo Pai; Jun-No Yun; Sang-Jin Park
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

Review 9.  New players driving inflammation in monogenic autoinflammatory diseases.

Authors:  Fabio Martinon; Ivona Aksentijevich
Journal:  Nat Rev Rheumatol       Date:  2014-09-23       Impact factor: 20.543

10.  A de novo sSMC(22) Characterized by High-Resolution Arrays in a Girl with Cat-Eye Syndrome without Coloboma.

Authors:  C Córdova-Fletes; M G Domínguez; A Vázquez-Cárdenas; L E Figuera; V A Neira; A Rojas-Martínez; R Ortiz-López
Journal:  Mol Syndromol       Date:  2012-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.